MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Search

Savara Inc

Chiusa

SettoreSettore sanitario

2.39 4.37

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.2

Massimo

2.42

Metriche Chiave

By Trading Economics

Entrata

2.4M

-27M

Margine di Profitto

-10,677.941

Dipendenti

59

EBITDA

2.7M

-28M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+204.35% upside

Dividendi

By Dow Jones

Utili prossimi

8 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-117M

404M

Apertura precedente

-1.98

Chiusura precedente

2.39

Notizie sul Sentiment di mercato

By Acuity

41%

59%

147 / 376 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Neutral Evidence

Savara Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 lug 2025, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

FCC Approves U.S. Cellular Sale to T-Mobile

11 lug 2025, 17:28 UTC

I principali Market Mover

SharpLink Gaming Gains on Ethereum Purchase

11 lug 2025, 16:57 UTC

Utili

BASF Cuts Outlook on Global Economy Uncertainty

11 lug 2025, 21:45 UTC

Discorsi di Mercato

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 lug 2025, 19:46 UTC

Acquisizioni, Fusioni, Takeovers

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 lug 2025, 19:45 UTC

Discorsi di Mercato

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 lug 2025, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 lug 2025, 18:18 UTC

Discorsi di Mercato

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 lug 2025, 17:35 UTC

Discorsi di Mercato

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 lug 2025, 17:26 UTC

Discorsi di Mercato

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 lug 2025, 16:53 UTC

Discorsi di Mercato

Crude Futures Add to Early Gains -- Market Talk

11 lug 2025, 16:42 UTC

Utili

BASF Cuts Outlook on Global Economic Uncertainty

11 lug 2025, 16:08 UTC

Discorsi di Mercato

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 lug 2025, 16:05 UTC

Utili

BASF Will Publish Half-Year Results on July 30

11 lug 2025, 16:04 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

11 lug 2025, 16:04 UTC

Discorsi di Mercato

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11 lug 2025, 16:03 UTC

Utili

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11 lug 2025, 16:02 UTC

Utili

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11 lug 2025, 16:01 UTC

Utili

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11 lug 2025, 16:00 UTC

Utili

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11 lug 2025, 15:59 UTC

Utili

BASF Cuts 2025 Earnings View

11 lug 2025, 15:58 UTC

Utili

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11 lug 2025, 15:57 UTC

Utili

BASF 2Q EBIT Before Special Items EUR810M

11 lug 2025, 15:54 UTC

Utili

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

11 lug 2025, 15:54 UTC

Utili

BASF 2Q Sales Fell 2.1% on Year

11 lug 2025, 15:53 UTC

Utili

BASF 2Q Sales EUR15.77B

11 lug 2025, 15:52 UTC

Utili

BASF: This Was in Line With Consensus Estimates

11 lug 2025, 15:52 UTC

Utili

BASF 2Q Ebitda Before Special Items EUR1.77B

11 lug 2025, 15:49 UTC

Utili

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

11 lug 2025, 15:41 UTC

Discorsi di Mercato

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Confronto tra pari

Modifica del prezzo

Savara Inc Previsione

Obiettivo di Prezzo

By TipRanks

204.35% in crescita

Previsioni per 12 mesi

Media 7 USD  204.35%

Alto 16 USD

Basso 2 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Savara Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

5

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

2.76 / 2.84Supporto e resistenza

A breve termine

Neutral Evidence

A termine intermedio

Very Strong Bullish Evidence

A lungo termine

Weak Bullish Evidence

Sentiment

By Acuity

147 / 376 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.